A Randomized Trial of Insulin Glargine plus Oral Hypoglycemic Agents versus Continuous Subcutaneous Insulin Infusion to Treat Newly Diagnosed Type 2 Diabetes

AIMS: Basal insulin plus oral hypoglycemic agents (OHAs) has not been investigated for early intensive antihyperglycemic treatment in people with newly diagnosed type 2 diabetes. This study is aimed at comparing the short-term (over a period of 12 days) effects of basal insulin glargine plus OHAs an...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Diabetes Res
Main Authors: Lin, Shuo, Chen, Mu, Chen, Wanling, Lin, Keyi, Mu, Panwei, Zhu, Bilian, Xu, Wen, Wang, Manman, Weng, Jianping, Zeng, Longyi
Formato: Artigo
Idioma:Inglês
Publicado em: Hindawi 2018
Assuntos:
Clinical Study
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6215559/
https://ncbi.nlm.nih.gov/pubmed/30420969
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2018/2791584
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados